Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00287040 · ClinicalTrials.gov registry record · Phase 3

Breast Cancer Screening Via Computer V. Phone

A Phase 3 study of Breast Cancer Screening, sponsored by Indiana University.

Completed
Registry status
Phase 3
Development phase
1,686
Enrollment target
2
Study locations

NCT00287040 is a Phase 3 study of Breast Cancer Screening that has completed, run by Indiana University. The registered enrollment target is 1,686 participants, below the 63,231-participant average among 8 other Breast Cancer Screening trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00287040, a Phase 3 study of Breast Cancer Screening, has completed, sponsored by Indiana University.

COMPLETED
Registry status
Phase 3
Development phase
1,686 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to compare mammography adherence among women receiving tailored, interactive mammography interventions via DVD and telephone counseling to usual care.

Conditions Studied

Interventions

  • BEHAVIORAL Tailored, interactive intervention for mammography screening

Study Locations (2)

Indiana

  • Indiana University - Indianapolis

North Carolina

  • Duke University - Durham

Trial Details

FieldValue
Enrollment Target 1,686 participants
Start Date 2007-09
Est. Completion 2009-06
Phase Phase 3

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT00287040

The ClinicalTrials.gov registry entry for NCT00287040 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,686 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 63,231-participant average among 8 other Breast Cancer Screening trials with a reported enrollment target (97% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer Screening appearing as the primary indexed condition, and to 1 intervention - of which Tailored, interactive intervention for mammography screening is the first listed.

NCT00287040 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Indiana, North Carolina.

Frequently Asked Questions

What is clinical trial NCT00287040 about?

NCT00287040 is a clinical study titled "Breast Cancer Screening Via Computer V. Phone". The purpose of this study is to compare mammography adherence among women receiving tailored, interactive mammography interventions via DVD and telephone counseling to usual care.

What is the current status of trial NCT00287040?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,686 participants. The study started on 2007-09. Estimated completion is 2009-06.

What conditions does trial NCT00287040 study?

This clinical trial studies the following conditions: Breast Cancer Screening.

What interventions are being tested in trial NCT00287040?

The interventions under investigation include: Tailored, interactive intervention for mammography screening (BEHAVIORAL).

Who is sponsoring clinical trial NCT00287040?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00287040 being conducted?

This trial has 2 study locations across Indiana, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer Screening

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.